SEC Form 4/A · accession 0001179110-15-009971
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Scott A Holmes
Officer — SVP, Finance and Treasurer
Period of report
Jun 3, 2015
Accepted (ET)
Jun 17, 2015 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 3, 2015 | M | 3,750 | $14.38 | A | 34,538 | D | |
| Common StockF1 | Jun 3, 2015 | M | 12,891 | $14.89 | A | 47,429 | D | |
| Common StockF1 | Jun 3, 2015 | M | 5,875 | $21.13 | A | 53,304 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $14.38 | Jun 3, 2015 | M | 3,750 | A | — | Sep 12, 2021 | Common Stock | 3,750 | 1,250 | D |
| Stock Option (Right to Buy)F3,F1 | $14.89 | Jun 3, 2015 | M | 12,891 | A | — | Jun 25, 2019 | Common Stock | 12,891 | 17,109 | D |
| Stock Option (Right to Buy)F4,F1 | $21.13 | Jun 3, 2015 | M | 5,875 | A | — | Feb 27, 2024 | Common Stock | 5,875 | 12,925 | D |
Explanation of responses
- F1This transaction was omitted from the reporting person's original Form 4. Following all of the transactions undertaken by the reporting person on June 3, 2015, the reporting person beneficially owned 53,304 shares of AMAG Pharmaceuticals, Inc. common stock.
- F2This option vests and becomes exercisable in four equal annual installments on September 12, 2012, September 12, 2013, September 12, 2014 and September 12, 2015.
- F3This option vests and becomes exercisable over four years from the grant date (June 25, 2012), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.
- F4This option vests and becomes exercisable over four years from the grant date (February 27, 2014), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.